Feng, M., Smith, D. E., Normolle, D. P., Knol, J. A., Pan, C. C., Ben-Josef, E., . . . Lawrence, T. S. (2012). A Phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.
استشهاد بنمط شيكاغوFeng, Mary, et al. A Phase I Clinical and Pharmacology Study Using Amifostine As a Radioprotector in Dose-escalated Whole Liver Radiation Therapy. 2012.
MLA استشهادFeng, Mary, et al. A Phase I Clinical and Pharmacology Study Using Amifostine As a Radioprotector in Dose-escalated Whole Liver Radiation Therapy. 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.